Results of the 2nd Planned Interim Analysis of the RAPID Trial (involved field radiotherapy versus no further treatment) in Patients with Clinical Stages 1A and 2A Hodgkin Lymphoma and a 'negative' FDG-PET Scan after 3 Cycles ABVD

被引：0
|
作者：
Radford, John [1 ,2 ]
O'Doherty, Michael [3 ]
Barrington, Sally [3 ]
Qian, Wendi [4 ]
Patrick, Philippa [5 ]
Coltart, Stewart [6 ]
Culligan, Dominic [7 ]
Wimperis, Jennie [8 ]
Bessell, Eric [9 ]
Linch, David
Johnson, Peter
Cunningham, David
Lister, T. Andrew
Hoskin, Peter
Pettengell, Ruth
Hancock, Bary
Illidge, Timothy [1 ,2 ]
机构：
[1] Christie Hosp, Manchester, Lancs, England
[2] Univ Manchester, Manchester, Lancs, England
[3] St Thomas Hosp, PET Imaging Ctr, London, England
[4] MRC Canc Trials Unit, London, England
[5] Canc Res UK & Univ Coll London, Clin Trials Ctr, London, England
[6] Kent & Canterbury Hosp, Canterbury, Kent, England
[7] Aberdeen Royal Infirm, Aberdeen, Scotland
[8] Norfolk & Norwich Univ Hosp, Norwich, Norfolk, England
[9] City Hosp Nottingham, Nottingham, England
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：143 / 144
页数：2
相关论文
共 8 条
  • [1] RESULTS OF THE 3RD PLANNED INTERIM ANALYSIS OF THE UK NCRI RAPID TRIAL (INVOLVED FIELD RADIOTHERAPY VERSUS NO FURTHER TREATMENT) IN PATIENTS WITH CLINICAL STAGES IA/IIA HODGKIN LYMPHOMA AND A 'NEGATIVE' 18FDG-PET SCAN AFTER 3 CYCLES ABVD
    Radford, J.
    O'Doherty, M.
    Barrington, S.
    Qian, W.
    Popova, B.
    Pettengell, R.
    Coltart, S.
    Culligan, D.
    Wimperis, J.
    Bessell, E.
    Linch, D.
    Cunningham, D.
    Lister, A.
    Hancock, B.
    Johnson, P.
    Hoskin, P.
    Illidge, T.
    HAEMATOLOGICA, 2010, 95 : S16 - S17
  • [2] Interim results of a UK NCRI randomised trial comparing involved field radiotherapy with no further treatment after 3 cycles ABVD and a negative PET scan in clinical stages IA/IIA Hodgkin lymphoma
    Radford, J. A.
    Barrington, S. F.
    O'Doherty, M. J.
    Qian, W.
    Mouncey, P.
    Pettengell, R.
    Hoskin, P.
    Bessell, E. M.
    Coltart, R. S.
    Cunningham, D.
    Culligan, D.
    Hatton, C.
    Johnson, P. W. M.
    Kruger, A.
    Linch, D.
    Lister, T. A.
    Marcus, R.
    Sadullah, S.
    Wimperis, J.
    Hancock, B. W.
    Illidge, T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 32 - 32
  • [3] FDG-PET for treatment response assessment in advanced stage Hodgkin Lymphoma -: report on the 2nd interim analysis of GHSG trial HD15
    Eich, H. T.
    Kobe, C.
    Dietlein, M.
    Kriz, J.
    Zimmermann, C.
    Skripnitchenko, R.
    Pluetschow, A.
    Engert, A.
    Mueller, R. -P.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2008, 184 : 11 - 11
  • [4] FDG-PET FOR ASSESSMENT OF RESIDUAL TISSUE AFTER COMPLETION OF CHEMOTHERAPY IN HODGKIN LYMPHOMA REPORT ON THE 2ND INTERIM ANALYSIS OF THE PET INVESTIGATION IN THE TRIAL HD15 OF THE GHSG
    Fuchs, M.
    Haverkamp, H.
    Dietlein, M.
    Diehl, V.
    Engert, A.
    Kobe, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 190 - 190
  • [5] FDG-PET for Assessment of Residual Tissue after Completion of Chemotherapy in Hodgkin Lymphoma - report on the 2nd interim analysis of the PET investigation in the trial HD15 of the German Hodgkin Study Group (GHSG)
    Kobe, C.
    Dietlein, M.
    Franklin, J.
    Eich, H. T.
    Gossmann, A.
    Engert, A.
    Schicha, H.
    Amthauer, H.
    Kluthmann, S.
    Knapp, W. H.
    Bockisch, A.
    Weckesser, M.
    Lorenz, R.
    Schreckenberger, M.
    Bares, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S144 - S144
  • [6] Involved-Field Radiation Therapy Prevents Recurrences in the Early Stages of Hodgkin Lymphoma in PET-Negative Patients After ABVD Chemotherapy: Relapse Analysis of GHSG Phase 3 HD16 Trial
    Baues, Christian
    Goergen, Helen
    Fuchs, Michael
    Rosenbrock, Johannes
    Celik, Eren
    Eich, Hans
    Kobe, Carsten
    Voltin, Conrad-Amadeus
    Engert, Andreas
    Borchmann, Peter
    Marnitz, Simone
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (04): : 900 - 906
  • [7] Dose-intensified combined modality treatment with 2 cycles of BEACOPP escalated followed by 2 cycles of ABVD and Involved Field Radiotherapy (IF-RT) is superior to 4 cycles of ABVD and IFRT in patients with early unfavourable Hodgkin Lymphoma (HL): An analysis of the GHSG HD14 trial
    Eich, H. T.
    Borchmann, P.
    Kriz, J.
    Pluetschow, A.
    Fuchs, M.
    Engert, A.
    Mueller, R. -P.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2010, 186 : 77 - 77
  • [8] Dose-Intensified Combined Modality Treatment with 2 Cycles of BEACOPP Escalated Followed by 2 Cycles of ABVD and Involved Field Radiotherapy (IF-RT) Is Superior to 4 Cycles of ABVD and IF-RT in Patients with Early Unfavourable Hodgkin Lymphoma (HL): An Analysis of the German Hodgkin Study Group (GHSG) HD14 Trial
    Borchmann, Peter
    Engert, Andreas
    Pluetschow, Annette
    Fuchs, Michael
    Markova, Jana
    Lohri, Andreas
    Kral, Zdenek
    Greil, Richard
    Topp, Max
    Villalobos, Matthias
    Zijlstra, Jose
    Soekler, Martin
    Stein, Harald
    Eich, Hans Theodor
    Mueller, Rolf Peter
    Diehl, Volker
    BLOOD, 2008, 112 (11) : 143 - 143
1